Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

Phase 4

• Conditions: Pain Management and Care
• Interventions: Drug: MEOPA

• Registration Number: NCT02230007
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication.

The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person.

The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-05-07
• Study Start: 2013-06
• Status Verified: 2013-12
• Study First Submitted QC: 2014-09-02
• Last Update Submitted: 2014-09-02
• Study First Posted: 2014-09-03
• Last Update Posted: 2014-09-03
• Primary Completion: 2015-05
• Study Completion: 2015-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Male or female aged 65 years old or more
• Patients having a prescription for physiotherapy
• Absence of contraindication to MEOPA
• Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus
• Patients whose reeducation project established by the physiotherapist
• Patients having agreed to participate in the study and having signed the consent
• Subjects affiliated to the social security system

Exclusion Criteria

• Patient requiring a ventilation in pure oxygen
• Patient with a consciousness deterioration preventing his cooperation
• Care under MEOPA during the period of the protocol and during the month which precedes
• Increase of the dosage of morphine of less than 48 hours Patient under guardianship

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
MEOPA	MEOPA	ENTONOX (MEOPA)gas Duration of treatment of a subject according to the protocol: 60 MINUTES Inhalation use

Primary Outcome Measures

Name	Time	Method
% of recovery of the hip and knee joint articular amplitude	5 days	% of recovery of the hip and knee joint articular amplitude during 5 days after 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment; measure % of recovery of the hip and knee joint articular amplitude two times : before the beginning of the session of reeducation and at the end of the session

Secondary Outcome Measures

Name	Time	Method
Measure of the pain	5 days	Patient answer a questionnaire on his pain at the beginning of each session of reeducation (5 sessions)
Patients'satisfaction	End of the period of care (up to 5 days)	Patient answer a questionnaire on this satisfaction at the end of the period of care of the protocol.
Physiotherapists'satisfaction	End of all the period of care (up to 5 days)	Physiotherapists answer a questionnaire on this satisfaction of the use of the MEOPA

Trial Locations

Locations (2)

CHU de Nice; 🇫🇷 Nice, France

Pôle de Gérontologie Hôpital de Cimiez CHU de Nice; 🇫🇷 Nice, France